Klaus Schollmeier

Director/Board Member at HEIDELBERG PHARMA AG

69 year

Health Technology

Consumer Services

Finance

Profile

Currently, Klaus Schollmeier is Chairman at Anergis SA, Eternygen GmbH, and TACALYX GmbH; Chairman-Supervisory Board at Inthera Bioscience AG; Member-Supervisory Board at Heidelberg Pharma AG, Minaris Regenerative Medicine GmbH, Novaliq GmbH; and Independent Member-Supervisory Board at CureVac NV.
Formerly, the roles include Chief Executive Officer at SuppreMol GmbH (2013–2015), Chairman at Santhera Pharmaceuticals Holding AG (2011–2012), Chairman at PCOVERY ApS, Managing Director at ING BHF-Bank AG, Senior Director-Biotechnology at BASF Bioresearch Corp.
(1989–1993), Director at Graffinity Pharmaceuticals AG, Principal at Knoll AG and Abbott GmbH (Germany), Research Associate Professor-Medical School at Boston University, General Manager at BASF Pharma (1996–1998), and Member-Supervisory Board at Modra Pharmaceuticals BV.
Education includes a doctorate from Heinrich-Heine-Universität Düsseldorf conferred in 1991.

Klaus Schollmeier active positions

Companies	Position	Start
CUREVAC	Director/Board Member	2022-06-21
HEIDELBERG PHARMA AG	Director/Board Member	2025-05-14
Minaris Regenerative Medicine GmbH Minaris Regenerative Medicine GmbH BiotechnologyHealth Technology Develops cell-based and gene therapy products	Director/Board Member	-
Eternygen GmbH Eternygen GmbH Pharmaceuticals: MajorHealth Technology Engages in the research and development of drugs	Chairman	-
TACALYX GmbH TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services Develops therapeutics targeting cancer-specific carbohydrate antigens for metastatic malignant tumors	Chairman	2020-11-04
Inthera Bioscience AG Inthera Bioscience AG BiotechnologyHealth Technology Develops, manufactures small bio molecule therapies for solid tumors	Chairman	-
Anergis SA Anergis SA Pharmaceuticals: GenericHealth Technology Provides allergy vaccines	Chairman	-
Novaliq GmbH Novaliq GmbH Medical SpecialtiesHealth Technology Develops and markets drug delivery systems	Director/Board Member	-

All active positions of Klaus Schollmeier

Former positions of Klaus Schollmeier

Companies	Position	End
ING BHF-Bank AG ING BHF-Bank AG Major BanksFinance Provides banking services	Corporate Officer/Principal	2018-12-05
░░░░░░░░░ ░░░░	░░░░░ ░░░░░░░░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░	░░░░░░░░	-
░░░░ ░░░░░░	░░░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░░░░░ ░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░

See the detail of Klaus Schollmeier's experience

Training of Klaus Schollmeier

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Klaus Schollmeier's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	20
Abbott GmbH (Germany) Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical, diagnostic, nutritional, and hospital products	Health Technology
Knoll AG Knoll AG Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	Health Technology
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ING BHF-Bank AG ING BHF-Bank AG Major BanksFinance Provides banking services	Finance
Graffinity Pharmaceuticals AG Graffinity Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Specializes in chemical genomics pharmaceutical products	Health Technology
Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases	Health Technology
Heidelberg Pharma AG Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies	Health Technology
Heinrich-Heine-Universität Düsseldorf Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BASF Bioresearch Corp.
SuppreMol GmbH SuppreMol GmbH Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases	Health Technology
Anergis SA Anergis SA Pharmaceuticals: GenericHealth Technology Provides allergy vaccines	Health Technology
BASF Pharma
Pcovery ApS Pcovery ApS Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of invasive fungal infections	Health Technology
Eternygen GmbH Eternygen GmbH Pharmaceuticals: MajorHealth Technology Engages in the research and development of drugs	Health Technology
Novaliq GmbH Novaliq GmbH Medical SpecialtiesHealth Technology Develops and markets drug delivery systems	Health Technology
Minaris Regenerative Medicine GmbH Minaris Regenerative Medicine GmbH BiotechnologyHealth Technology Develops cell-based and gene therapy products	Health Technology
Inthera Bioscience AG Inthera Bioscience AG BiotechnologyHealth Technology Develops, manufactures small bio molecule therapies for solid tumors	Health Technology
Modra Pharmaceuticals BV Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Designs and develops oral formulations of commonly used anti-cancer drugs	Health Technology
TACALYX GmbH TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services Develops therapeutics targeting cancer-specific carbohydrate antigens for metastatic malignant tumors	Commercial Services
CureVac NV CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies	Health Technology